Multicenter validation study of the %CDT TIA kit in alcohol abuse and alcohol dependence

Alcoholism: Clinical and Experimental Research

Volumn 28, Issue 9, 2004, Pages 1331-1337

  Schwan, Raymund ^a,h   Loiseaux, Marie Nadia ^a   Schellenberg, François ^b   Albuisson, Eliane ^e   Favre, Jean Dominique ^c   Rigaud, Alain ^d   Llorca, Pierre Michel ^a   Gillet, Claudine ^f   Reynaud, Michel ^g  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

^c Department of Psychiatry   (France)

^d Department of Psychiatry   (France)

^e University Hospital Center ^*  (France)

^f UNIVERSITY HOSPITAL OF NANCY   (France)

^g Medical School   (France)

^h Centre Médico Psychologique B   (France)

Author keywords

CDT TIA; Glutamyl Transferase; Alcohol Abuse; Alcohol Dependence; Carbohydrate Deficient Transferrin

Indexed keywords

CARBOHYDRATE DEFICIENT TRANSFERRIN; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALCOHOL ABUSE; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; FEMALE; FRANCE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

ADULT; ALCOHOLISM; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; STATISTICS, NONPARAMETRIC; TRANSFERRIN;

EID: 4544384602     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000139813.14716.CD     Document Type: Article

References (50)

1. Allen JP, Anton R (2003) Biomarkers as aids to identification of relapse in alcoholic patients. Recent Dev Alcohol 16:25-38.
2. Allen JP, Litten RZ (2001) The role of laboratory tests in alcoholism treatment. J Subst Abuse Treat 20:81-85.
3. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 4th ed. American Psychiatric Association, Washington, DC.
4. American Psychiatric Association (1995) Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. Am J Psychiatry (11 Suppl) 152:1-59.
5. Anton RF (2001) Carbohydrate-deficient transferrin for detection and monitoring of sustained heavy drinking. What have we learned? Where do we go from here? Alcohol 25:185-188.
6. Anton RF, Dominick C, Bigelow M, Westby C (2001) Comparison of Bio-Rad %CDT TIA and CDTect as laboratory markers of heavy alcohol use and their relationships with gamma-glutamyltransferase. Clin Chem 47:1769-1175.
7. Arndt T (2001) Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation. Clin Chem 47:13-27.
8. Arndt T, Korzec A, Bar M, Kropf J (2002) Further arguments against including trisialo-Fe2-transferrin in carbohydrate-deficient transferrin (CDT): a study on male alcoholics and hazardous drinkers. Med Sci Monit 8:CR411-CR418.
9. Bien TH, Miller WR, Tonigan JS (1993) Brief interventions for alcohol problems: a review. Addiction 88:315-335.
10. Bortolotti F, Tagliaro F, Cittadini F, Gottardo R, Trettene M, Marigo M (2002) Determination of CDT, a marker of chronic alcohol abuse, for driving license issuing: immunoassay versus capillary electrophoresis. Forensic Sci Int 128:53-58.
11. Brienza RS, Stein MD (2002) Alcohol use disorders in primary care: do gender-specific differences exist? J Gen Intern Med 17:387-397.
12. Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, Helander A, Tabakoff B (2002) CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res 26:332-339.
13. Fleming MF, Barry KL, Manwell LB, Johnson K, London R (1997) Brief physician advice for problem alcohol drinkers. JAMA 277:1039-1045.
14. The French Society of Alcohology [Société français d'alcoologie] (2003) Les Mésusage d'alcool en dehors de la dépendance, alcoologie et addictologie 25:755-875.
15. Gutjahr E, Gmel G (2001) Defining alcohol-related fatal medical conditions for social-cost: 26 studies in Western societies-an update of the epidemiological evidence. J Subst Abuse 13:239-264.
16. Hasin DS, Grant B, Endicott J (1990) The natural history of alcohol abuse: implications for definitions of alcohol use disorders. Am J Psychiatry 147:1537-1541.
17. Hearne R, Connolly A, Sheehan J (2002) Alcohol abuse: prevalence and detection in a general hospital. J R Soc Med 95:84-87.
18. Helander A, Eriksson G, Stibler H, Jeppsson JO (2001a) Interference of transferrin isoform types with carbohydrate-deficient transferrin quantification in the identification of alcohol abuse. Clin Chem 47:1225-1233.
19. Helander A, Fors M, Zakrisson B (2001b) Study of Axis-Shield new % CDT immunoassay for quantification of carbohydrate-deficient transferrin (CDT) in serum. Alcohol Alcohol 36:406-412.
20. Holder HD (1987) Alcoholism treatment and potential health care cost savings. Med Care 25:52-71.
21. Holder HD, Bose JD (1992) The reduction of health care costs associated with alcoholism treatment: a 14 year longitudinal study. J Stud Alcohol 53:293-302.
22. Legros FJ, Nuyens V, Baudoux M, Zouaoui Boudjeltia K, Ruelle JL, Colicis J, Cantraine F, Henry JP (2003) Use of capillary zone electrophoresis for differentiating excessive from moderate alcohol consumption. Clin Chem 49:440-449.
23. Lesch OM, Walter H, Anal J (1996) Carbohydrate-deficient transferrin as a marker of alcohol intake: a study with healthy subjects. Alcohol Alcohol 31:265-271.
24. Litten RZ, Allen JP, Fertig JB (1995) Gamma-glutamyltranspeptidase and carbohydrate deficient transferrin: alternative measures of excessive alcohol consumption. Alcohol Clin Exp Res 19:1541-1546.
25. Malet L, Llorca PM, Boussiron D, Schwan R, Facy F, Reynaud M (2003) General practitioners and alcohol use disorders: quantity without quality. Alcohol Clin Exp Res 27:61-66.
26. Manwell LB, Ignaczak M, Czabala JC (2002) Prevalence of tobacco and alcohol use disorders in Polish primary care settings. Eur J Public Health 12:139-144.
27. Moore RD, Bone LR, Geller G, Mannon JA, Stoke EJ, Levine DM (1989) Prevalence, detecting and treatment of alcoholism in hospitalized patients. JAMA 261:403-407.
28. Moyer A, Finney JW, Swearingen CE, Vergun P (2002) Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction 97:279-292.
29. O'Connor PG, Schottenfeld RS (1998) Patients with alcohol problems. N Engl J Med 338:592-602.
30. Reynaud M, Gaudin-Colombel AF, Le Pen C (2001a) Two methods of estimating health costs linked to alcoholism in France (with a note on social costs). Alcohol Alcohol 36:89-95.
31. Reynaud M, Hourcade F, Planche F, Albuisson E, Meunier MN, Planche R (1998) Usefulness of carbohydrate-deficient transferrin in alcoholic patients with normal gamma-glutamyltranspeptidase. Alcohol Clin Exp Res 22:1-4.
32. Reynaud M, Malet L, Facy F, Glanddier P (2000a) Hospital morbidity of alcohol use disorders in the center of France. Alcohol Clin Exp Res 24:1057-1062.
33. Reynaud M, Schellenberg F, Loiseaux-Meunier MN, Schwan R, Maradeix B, Planche F, Gillet C (2000b) Objective diagnosis of alcohol abuse: compared values of carbohydrate-deficient transferrin (CDT), gamma-glutamyl transferase (GGT) and mean corpuscular value (MCV). Alcohol Clin Exp Res 24:1414-1419.
34. Reynaud M, Schwan R, Loiseaux-Meunier MN, Albuisson E, Deteix P (2001b) Patients admitted to emergency services for drunkenness: moderate alcohol users or harmful drinkers. Am J Psychiatry 158:96-99.
35. Saini RS, Pettinati HM, Semwanga AE, O'Brien P (1997) Carbohydrate-deficient transferrin: an investigative biochemical marker of heavy alcohol consumption. Psychopharmacol Bull 33:171-175.
36. Schellenberg F, Bénard J, Le Goff A, Bourdin C, Weill J (1989) Evaluation of carbohydrate-deficient transferrin compared with Tf index and other markers of alcohol abuse. Alcohol Clin Exp Res 13:605-610.
37. Schellenberg F, Mennetrey L, Bacq Y, Pages JC (2001) Carbohydrate- deficient transferrin (CDT) determination by nephelometry using a commercial kit. Analytical and diagnostic aspects. Clin Chem Lab Med 39:866-871.
38. Schwan R, Albuisson E, Malet L, Loiseaux MN, Reynaud M, Schellenberg F, Brousse G, Llorca PM (2004a) The use of biological laboratory markers in the diagnosis of alcohol misuse: an evidence-based approach. Drug Alcohol Depend 74:273-279
39. Schwan R, Malet L, Loiseaux MN, Llorca PM (2004b) Which types of alcohol-use disorder will asialotransferrin detect? Clin Chem 50:782.
40. Sharp PC (2001) Biochemical detection and monitoring of alcohol abuse and abstinence. Ann Clin Biochem 38:652-664.
41. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22-33.
42. Sillanaukee P (1996) Laboratory markers of alcohol abuse. Alcohol Alcohol 31:613-616.
43. Sillanaukee P, Aalto M, Seppa K (1998) Carbohydrate-deficient transferrin and conventional alcohol markers as indicators for brief intervention among heavy drinkers in primary health care. Alcohol Clin Exp Res 22:892-896.
44. Sillanaukee P, van der Gaag MS, Sierksma A, Hendriks HF, Strid N, Ponnio M, Nikkari ST (2003) Effect of type of alcohol beverages on carbohydrate- deficient transferrin, sialic acid, and liver enzymes. Alcohol Clin Exp Res 27:57-60.
45. Stibler H (1991) Carbohydrate deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 37:2029-2037.
46. Stibler H, Allgulander C, Borgs S, Kjellin KG (1978) Abnormal microheterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism. Acta Med Scand 204:49-56.
47. Weill J, Schellenberg F (1993) The mathematics of measurement: sensitivity, specificity and predictive value of available tests. Alcohol Alcohol 2:107-110.
48. Wilk AL, Maisto SA, Connors GJ (1997) Meta-analysis of randomized control trials addressing brief interventions in heavy alcohol drinkers. J Gen Intern Med 12:274-283.
49. Woodward B, Fortgang J, Sullivan-Trainor M, Stojanov H, Mirin SM (1991) Underdiagnosis of alcohol dependence in psychiatric inpatients. Am J Drug Alcohol Abuse 17:373-388.
50. Yersin B, Nocolet JF, Decrey H, Burnier M, van Melle G, Pécoud A (1995) Screening for excessive alcohol drinking: comparative value of carbohydrate-deficient transferrin, gamma-glutamyl transferase, and mean corpuscular volume. Arch Intern Med 155:1907-1911.